
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About XBiotech
XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies for treating a variety of diseases, such as cancer, vascular disease, inflammatory skin disease, and diabetes.
Stock Analysis

last close
$5.59
1-mo return
-22.8%
3-mo return
-43.3%
avg daily vol.
111.85T
52-week high
16.95
52-week low
5.37
market cap.
$171M
forward pe
-
annual div.
-
roe
-6.6%
ltg forecast
-
dividend yield
-
annual rev.
$14M
inst own.
20.7%